Commission Delegated Regulation (EU) 2026/863 of 20 April 2026 correcting certain language versions of Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act included in a Joint Committee Decision (JCD); entry into force of the Decision is pending
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
302/2026
Legal Documents
Commission Delegated Regulation (EU) 2026/863 of 20 April 2026 correcting certain language versions of Regulation (EC) No 1234/2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use
Delegierte Verordnung (EU) 2026/863 der Kommission vom 20. April 2026 zur Berichtigung bestimmter Sprachfassungen der Verordnung (EG) Nr. 1234/2008 über die Prüfung von Änderungen der Zulassungen von Humanarzneimitteln
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.